|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Number of the document | 2152917 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08755809.4 |
| Date of filing the European patent application | 2008-05-17 | |
| (97) | Date of publication of the European application | 2010-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/064027 |
| Date | 2008-05-17 |
| (87) | Number | WO 2008/144599 |
| Date | 2008-11-27 |
| (30) | Number | Date | Country code |
| 939033 P | 2007-05-18 | US |
| (72) |
LAVEDAN, Christian, US
VOLPI, Simona, US
LICAMELE, Louis, US
POLYMEROPOULOS, Mihael, H., US
|
| (73) |
Vanda Pharmaceuticals Inc.,
9605 Medical Center Drive, Suite 300, Rockville NY 20850,
US
|
| (54) | GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS |
| GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS |